OncoMatch/Clinical Trials/NCT07824583
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Official title: A ProSPEctivE Study of NGDS DMAT Workflow Feasibility
Is NCT07824583 recruiting? Yes, currently enrolling (Oct 2026). This NA trial studies Next Generation Delivery System (NGDS) for lung cancer (diagnosis).
Treatment: Next Generation Delivery System (NGDS) — The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering radiation in shorter treatment time and better patient tolerance, with less breath holding.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Non-Small Cell Lung Carcinoma
Small Cell Lung Cancer
Hepatocellular Carcinoma
Pancreatic Cancer
Performance status
ECOG 0–1(Restricted strenuous activity)
Demographics
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Siteman Cancer Center Washington University · St Louis, Missouri
- University Hospital Cleveland Medical Center · Cleveland, Ohio
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07824583 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify